General Surgery

General Surgery

General Surgery ACS NSQIP Outcomes

January 1, 2024 – December 31, 2024

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall general surgery ACS NSQIP performance benchmarked against 653 participating sites.

General Surgery (653 Sites)NObservedExpected
30 Day Mortalityᵇ12390.48%1.99%
30 Day Morbidity123915.33%16.48%
Cardiac12390.81%1.15%
Pneumoniaᵇ12391.21%2.28%
Unplanned Intubation12391.61%1.43%
Ventilator > 48 Hours12331.30%1.36%
Deep Vein Thrombosis (DVT) / Pulmonary Embolusᵃ12394.04%2.40%
Renal Failure12362.99%2.59%
Urinary Tract Infection (UTI)12391.61%1.62%
Surgical Site Infection (SSI)12259.22%9.28%
Sepsisᵇ12191.39%3.26%
C.diff Colitisᵃ12391.45%0.68%
Unplanned Reoperationᵇ12394.28%5.32%
Unplanned Readmission123913.24%11.99%

American College of Surgeons National Surgical Quality Improvement Program, 2025.
ACS NSQIP® Semiannual Report July, 2025, Chicago: American College of Surgeons.

ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.

ᵇIdentified as a statistical outlier (lower than expected) by the ACS NSQIP hierarchical model.